Prostate Cancer Drugs Increase Risk of Osteoporosis, Fractures

Men with prostate cancer who are treated with androgen-suppressing GnRH analog drugs, are at markedly increased risk of osteoporosis and bone fractures compared with patients of similar age who are not taking these drugs. The longer a man is on a GnRH analog, the greater is his osteoporosis/fracture risk.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.
Subscribe to Holistic Primary Care